FzioMed Inc. Reports Promising Results Using Oxiplex Gel To Reduce Perivascular Adhesions In Preclinical Artificial Disc Surgery

SAN LUIS OBISPO, Calif.--(BUSINESS WIRE)--May 9, 2006--FzioMed, Inc. announced today the presentation of preclinical studies demonstrating that the company’s Oxiplex Gel was effective in reducing perivascular adhesions in artificial disc surgery. The poster presentation is being made at the Spine Arthroplasty Summit 6 (SAS6) of the Spine Arthroplasty Society held in Montreal, Quebec, Canada May 9 - 13, 2006.

MORE ON THIS TOPIC